Target intelligence / Profile preview

MIA-RAB4B readthrough transcript (MIA-RAB4B)

Target: MIA-RAB4B
Molecular classification: Long noncoding RNA (lncRNA), Competitive endogenous RNA (ceRNA)

Overview

MIA-RAB4B is a readthrough long noncoding RNA (lncRNA) resulting from transcriptional continuation across the MIA and RAB4B genes on chromosome 19q13. This lncRNA functions as a competitive endogenous RNA (ceRNA), capable of titrating away micro-RNA-24, thereby facilitating the upregulation of oncogenes such as PIM2 and TAOK1. Experimental studies have shown that MIA-RAB4B is upregulated in certain colorectal polyps, and this upregulation may contribute to tumorigenesis by derepressing critical downstream targets involved in cell growth and survival. While MIA-RAB4B is implicated in cancer-related molecular mechanisms, it is not a classical drug target (e.g., receptor, enzyme).

Other names: MIA-RAB4B read-through lncRNAMIA-RAB4B fusion transcript

Biological functions

Possible regulation of gene expression through ceRNA activitymiRNA titration (specifically sequestering micro-RNA 24, miR-24)May influence the expression of oncogenes including PIM2 and TAOK1 by derepression through miRNA interaction

Disease associations

Cancer (especially colorectal cancer, involvement suggested in polyps; may contribute to tumorigenesis)Tumor progression (by possibly upregulating oncogenes PIM2 and TAOK1)

Biomarkers

MIA-RAB4B expression has been suggested as a possible biomarker for colorectal neoplasia susceptibility but not validated for clinical use

Beyond the preview

Go deeper on MIA-RAB4B readthrough transcript (MIA-RAB4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MIA-RAB4B readthrough transcript (MIA-RAB4B).

Explore the full profile